The dip buyers (knife catchers?) are coming out this morning. My QQQQ intraday chart still looks bearish (it will look better above 41.50) so I’m not yet convinced to join in on the buying. Here are some stocks that have my attention this morning:
BAC — earnings miss
LEAP — $45 tgt and overweight rating from Lehman
PALM — pumped by ThinkEquity with a $50 tgt
GOOG — several analysts hyping pumping making bullish remarks
BIIB — drug news and a $55 tgt from Prudential
PLAY — $45 tgt from Soleil
GLD — JP Morgan says gold could hit $800
MSA – Mine safety back in the news
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
SUF -21% (profiled negatively in Barron’s Online; co to appear on CNBC today), STAA -3.4% (profit taking after 6% gain on Friday), SIRI -1.8% (profiled in Barron’s Online), BAC -1% (reports Q4), CHK -1%.
Gapping Up
RMBS +6% (increases stock buyback authorization), F +5.4% (reports Q4, beats handily, announces job cuts), MOSY +19% (positive Barron’s Online article), ZOLT +15% (Mad Money mention), QTWW +12% (Merriman upgrade), DCN +6% (in sympathy with Ford), REM +19% (to be acquired by CDIS), PETS +5.7% (reports DecQ), MDRX +5.3% (extends recent momentum), DHB +5% (wins body armor contract), MSA +4.8%, DUK +4.8%, ALDN +4.6% (reports Q4), COMS +4.5%, WFII +4.4% (contract win), GFI +4.1% (bounces after weakness on Friday), ABS +3.2% (co to be sold), SAP +3% (strength in tech stocks), ASML +2.8% (same), NUVO +2.8% (receives FDA fast track status for Alfimeprase), XMSR +2.4% (Barron’s Online profile), YHOO +2% (Bear Stearns upgrade), VOD +2%, CMED +2% (moves up on IBD list), AMTD +1.9% (Mad Money mention), GOOG +1.8% (Stanford upgrade), SNDK +1.5% (tech strong in pre-mkt), BRCM +1.1% (to acquire Sandburst).. Under $3: GNBT +25% (announces FDA meeting), IVAN +9% (bounces after 2 day fall), VION +9% (receives orphan drug designation).
Disclaimer & How I use this list
